Researchers assessed acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC).
atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates | Psychedelic Invest
NEW YORK and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of